INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 223 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,862,000 | -65.7% | 583,657 | -89.2% | 0.18% | -52.0% |
| Q1 2020 | $40,384,000 | +142.4% | 5,427,968 | +7.5% | 0.38% | +44.7% |
| Q4 2019 | $16,657,000 | +57.6% | 5,047,608 | -2.1% | 0.26% | +39.4% |
| Q3 2019 | $10,571,000 | -26.4% | 5,156,350 | +5.6% | 0.19% | -33.3% |
| Q2 2019 | $14,359,000 | +18.0% | 4,884,100 | +49.7% | 0.28% | -12.1% |
| Q1 2019 | $12,169,000 | – | 3,262,519 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |